selected publications
-
academic article
- A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.. International journal of cancer. 144:2192-2205. 2019
- Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.. Cancer research. 79:505-517. 2019
- Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.. British journal of cancer. 116:524-535. 2017
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. 53:800-811. 2016
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.. Cancer discovery. :-. 2016
- A targeted genetic association study of epithelial ovarian cancer susceptibility.. Oncotarget. 7:7381-7389. 2016
- Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.. Genetic epidemiology. :-. 2015
- Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. :-. 2015
- Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.. Gynecologic oncology. 136:542-548. 2015
- Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).. British journal of cancer. 112:925-933. 2015
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
- Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.. Nature communications. 6:-. 2015
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.. Gynecologic oncology. -. 2015